Mechanisms of cytokine-mediated localized immunoprotection.
Open Access
- 1 November 1996
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 184 (5) , 1597-1600
- https://doi.org/10.1084/jem.184.5.1597
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Tumor necrosis factor alpha inhibits signaling from the insulin receptor.Proceedings of the National Academy of Sciences, 1994
- Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic MouseClinical Immunology and Immunopathology, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans.The Journal of Experimental Medicine, 1993
- Antigen‐presenting cells in adoptively transferred and spontaneous autoimmune diabetesEuropean Journal of Immunology, 1993
- Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice.The Journal of Immunology, 1993
- Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.The Journal of Experimental Medicine, 1992
- Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γNature, 1990
- Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.Proceedings of the National Academy of Sciences, 1990
- Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.The Journal of Experimental Medicine, 1988